News
NSPR
3.000
+0.67%
0.020
Weekly Report: what happened at NSPR last week (1209-1213)?
Weekly Report · 5d ago
InspireMD Finance Chief Craig Shore To Retire
NASDAQ · 12/12 13:35
InspireMD CFO Retirement Amid Strategic Transition
TipRanks · 12/12 12:47
InspireMD CFO Craig Shore to retire
Seeking Alpha · 12/12 12:09
INSPIREMD ANNOUNCES EXPECTED RETIREMENT OF ITS CFO CRAIG SHORE AND CFO TRANSITION IN 2025
Reuters · 12/12 12:00
InspireMD Price Target Announced at $5.00/Share by Lake Street
Dow Jones · 12/11 18:59
Lake Street Initiates Coverage On InspireMD with Buy Rating, Announces Price Target of $5
Benzinga · 12/11 18:48
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study
NASDAQ · 12/11 17:17
InspireMD initiated with a Buy at Lake Street
TipRanks · 12/11 13:50
InspireMD Initiates CGUARDIANS II Clinical Trial for CGuard Prime Carotid Stent System
Barchart · 12/09 16:18
InspireMD Advances CGuard Prime with New Clinical Trial
TipRanks · 12/09 13:41
InspireMD announces first patient enrolled in CGUARDIANS II study
TipRanks · 12/09 12:21
InspireMD Enrolls First Patient in Clinical Trial for CGuard Carotid Stent System
Benzinga · 12/09 12:01
INSPIREMD ANNOUNCES FIRST PATIENT ENROLLED IN THE CGUARDIANS II PIVOTAL STUDY OF THE CGUARD PRIME CAROTID STENT SYSTEM IN TRANSCAROTID ARTERY REVASCULARIZATION PROCEDURES (TCAR)
Reuters · 12/09 12:00
Weekly Report: what happened at NSPR last week (1202-1206)?
Weekly Report · 12/09 10:32
InspireMD Q1 EPS $(6.45) Beats $(9.45) Estimate, Sales $1.03M Beat $1.00M Estimate
Benzinga · 12/04 09:11
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 12/03 21:05
Weekly Report: what happened at NSPR last week (1125-1129)?
Weekly Report · 12/02 10:32
InspireMD, Inc. Appoints Scott R. Ward to Board of Directors to Drive Stroke Prevention Innovation
Barchart · 11/26 01:20
InspireMD Strengthens Leadership with Scott R. Ward Appointment
TipRanks · 11/25 21:52
More
Webull provides a variety of real-time NSPR stock news. You can receive the latest news about Inspiremd through multiple platforms. This information may help you make smarter investment decisions.
About NSPR
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.